727Tip A Randomised Phase III Study of Tremelimumab (T) Plus Durvalumab (D) with or Without Lenvatinib Combined with Concurrent Transarterial Chemoembolisation (TACE) Versus TACE Alone in Patients (pts) with Locoregional Hepatocellular Carcinoma (HCC): EMERALD-3
ANNALS OF ONCOLOGY（2022）
关键词
Treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要